Related Experiment Video
Updated: Nov 19, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Bronchial thermoplasty for severe asthma].
V Héluain1, L Guilleminault2, C Hermant1
1Service de pneumologie, hôpital Larrey, université Paul-Sabatier, CHU Toulouse, Toulouse, France.
Bronchial thermoplasty, an endoscopic treatment for severe asthma, reduces exacerbations and emergency visits by targeting airway smooth muscle. Identifying responders remains key for optimizing this minimally-invasive therapy.
Area of Science:
- Pulmonology
- Medical Technology
- Asthma Management
Background:
- Severe asthma lacks effective long-term treatment options.
- Bronchial thermoplasty is the first approved endoscopic therapy for severe asthma.
- The procedure targets bronchial smooth muscle using radiofrequency energy.
Purpose of the Study:
- To review the principles, mechanisms, and clinical outcomes of bronchial thermoplasty.
- To discuss its current role in severe asthma management.
- To identify challenges in predicting treatment response.
Main Methods:
- Review of randomized controlled trials and clinical registry data.
- Analysis of bronchial thermoplasty's radiofrequency application.
- Discussion of responder phenotype identification.
Main Results:
- Bronchial thermoplasty significantly reduces rescue medication use, urgent care visits, and exacerbation rates.
- The technique is currently a last-line treatment due to a lack of predictive markers.
- Clinical data supports its efficacy in select severe asthma patients.
Conclusions:
- Bronchial thermoplasty offers a valuable therapeutic option for severe asthma.
- Further research is needed to identify predictive markers for treatment response.
- Characterizing the responder phenotype is crucial for optimizing bronchial thermoplasty use.
Related Concept Videos
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

